SWS Partners
GH icon

SWS Partners’s Guardant Health GH Stock Holding History

SWS Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.62M Sell
48,355
-26,227
-35% -$4.29M 1.85% 13
2026
Q2 		$11.2M Sell
74,582
-4,899
-6% -$533K 2.42% 9
2026
Q1 		$7.34M Buy
79,481
+2,272
+3% +$228K 1.81% 10
2025
Q4 		$7.89M Sell
77,209
-17,347
-18% -$1.55M 1.9% 11
2025
Q3 		$5.91M Buy
94,556
+1,479
+2% +$80.5K 1.44% 16
2025
Q2 		$4.84M Sell
93,077
-11,740
-11% -$524K 1.31% 18
2025
Q1 		$4.47M Sell
104,817
-16,071
-13% -$693K 1.47% 14
2024
Q4 		$3.69M Buy
120,888
+37,126
+44% +$1.04M 1.12% 20
2024
Q3 		$1.92M Buy
83,762
+4,905
+6% +$139K 0.61% 66
2024
Q2 		$2.28M Buy
78,857
+33,446
+74% +$779K 0.68% 59
2024
Q1 		$937K Sell
45,411
-560
-1% -$12K 0.28% 89
2023
Q4 		$1.24M Sell
45,971
-724
-2% -$19K 0.41% 80
2023
Q3 		$1.38M Buy
46,695
+2,663
+6% +$93.6K 0.51% 77
2023
Q2 		$1.58M Sell
44,032
-460
-1% -$13.2K 0.57% 75
2023
Q1 		$1.04M Buy
44,492
+3,391
+8% +$96.9K 0.39% 88
2022
Q4 		$1.12M Buy
41,101
+9,666
+31% +$442K 0.53% 70
2022
Q3 		$1.69M Buy
31,435
+5,970
+23% +$306K 0.78% 55
2022
Q2 		$1.03M Buy
25,465
+10,467
+70% +$519K 0.86% 55
2022
Q1 		$995K Buy
+14,998
New +$1.03M 0.65% 65

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

SWS Partners's GH Position: Q3 2026 in Review

SWS Partners reduced its Guardant Health (GH) stake by 35% in Q3 2026, selling an estimated $4.29M and leaving 48,355 shares worth $8.62M. The position accounts for 1.85% of the portfolio, ranked #13.

SWS Partners first reported a position in GH in Q1 2022 and has held it in 19 quarters since. The position peaked at $11.2M in Q2 2026. 414 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • SWS Partners held 48,355 shares of Guardant Health worth $8.62M as of Q3 2026.
  • SWS Partners sold 26,227 Guardant Health shares in Q3 2026, an estimated $4.29M.
  • Guardant Health made up 1.85% of SWS Partners's portfolio in Q3 2026, its #13 holding.
  • SWS Partners first reported a position in Guardant Health in Q1 2022 and has held it in 19 quarters since.
  • SWS Partners's Guardant Health position peaked at $11.2M in Q2 2026.
  • 414 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on SWS Partners's 13F filing for Q3 2026, filed 26 Oct 2026.